Devil On The Run
The Strange Case of a Contagious Tumor, an Endangered Animal, and a Radical New Strategy Against Cancer
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Prime members: New to Audible?Get 2 free audiobooks during trial.
Pick 1 audiobook a month from our unmatched collection.
Unlimited access to our all-you-can listen catalog of 150K+ audiobooks and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 30 days. Cancel anytime.
Pre-order for $22.49
-
Narrated by:
-
By:
-
David Quammen
In Devil on the Run David Quammen introduces us to the revolutionary new field of evolutionary oncology, which reframes cancer as an evolutionary process, arguing that tumors adapt, compete, and survive through natural selection—and that understanding this is key to better treatment.
Using the dramatic case of a contagious cancer in Tasmanian devils as an example, Quammen explores how cancer evolves within and sometimes between bodies, how cancer in certain animals teaches us about cancer in humans, and how this evolutionary model is reshaping oncology, leading to new therapies that treat cancer as a chronic disease, rather than a terminal diagnosis.
With his trademark talent for explaining complex scientific stories, Quammen puts the scientists and researchers at the center of the narrative—some of whom have themselves been affected by cancer, making their work all the more urgent. We see how scientific breakthroughs are in fact based on years of careful research and innovative thinking, and how one generation of scientists builds on the work of the one that came before it.
Blending narrative, science, history, and field reporting, Devil on the Run contends that future treatments may depend less on total eradication and more on managing cancer as a dynamic biological system, with hopeful new outcomes for cancer patients.
adbl_web_anon_alc_button_suppression_t1
No reviews yet